The impact of stereotactic laser ablation at a typical epilepsy center

Gabrielle T. Petito, Robert E. Wharen, Anteneh Feyissa, Sanjeet S. Grewal, John A Lucas, William O. Tatum

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Purpose Stereotactic laser ablation (SLA) is a novel form of epilepsy surgery for patients with drug-resistant focal epilepsy. We evaluated one hundred consecutive surgeries performed for patients with epilepsy to address the impact of SLA on our therapeutic approach, as well as patient outcomes. Methods A retrospective, single center analysis of the last one hundred neurosurgeries for epilepsy was performed from 2013 to 2015. Demographics, surgical procedures, and postoperative measures were assessed up to 5 years to compare the effect of SLA on outcome. Confidence intervals (CI) and comparative tests of proportions compared outcomes for SLA and resective surgery. Procedural categorical comparison used Chi-square and Kaplan–Meier curves. Student t-test was utilized for single variables such as age at procedure and seizure onset. Results One hundred surgeries for epilepsy yielded thirty-three SLAs and twenty-one resections with a mean of 21.7-month and 21.3-month follow-up, respectively. The temporal lobe was the most common target for SLA (92.6%) and resection (75%). A discrete lesion was present on brain magnetic resonance imaging (MRI) in 27/32 (84.4%) of SLA patients compared with 7/20 (35%) of resection patients with a normal MRI. Overall, 55–60% of patients became seizure-free (SF). Four of five patients with initial failure to SLA became SF with subsequent resection surgery. Complications were more frequent with resection although SF outcomes did not differ (Chi square; p = 0.79). Stereotactic laser ablation patients were older than those with resections (47.0 years vs. 35.4 years, p = 0.001). The mean length of hospitalization prior to discharge was shorter for SLA (1.18 days) compared with open resection (3.43 days; SD: 3.16 days) (p = 0.0002). Conclusion We now use SLA as a first line therapy at our center in patients with lesional temporal lobe epilepsy (TLE) before resection. Seizure-free outcome with SLA and resection was similar but with a shorter length of stay. Long-term follow-up is recommended to determine sustained SF status from SLA.

Original languageEnglish (US)
Pages (from-to)37-44
Number of pages8
JournalEpilepsy and Behavior
Volume78
DOIs
StatePublished - Jan 1 2018

Fingerprint

Laser Therapy
Epilepsy
Seizures
Magnetic Resonance Imaging
Partial Epilepsy
Temporal Lobe Epilepsy
Postoperative Care
Neurosurgery
Temporal Lobe
Length of Stay
Hospitalization
Demography
Confidence Intervals
Students

Keywords

  • Ablation
  • Epilepsy
  • Laser
  • Resection
  • Seizures
  • Surgery

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Behavioral Neuroscience

Cite this

The impact of stereotactic laser ablation at a typical epilepsy center. / Petito, Gabrielle T.; Wharen, Robert E.; Feyissa, Anteneh; Grewal, Sanjeet S.; Lucas, John A; Tatum, William O.

In: Epilepsy and Behavior, Vol. 78, 01.01.2018, p. 37-44.

Research output: Contribution to journalArticle

Petito, Gabrielle T. ; Wharen, Robert E. ; Feyissa, Anteneh ; Grewal, Sanjeet S. ; Lucas, John A ; Tatum, William O. / The impact of stereotactic laser ablation at a typical epilepsy center. In: Epilepsy and Behavior. 2018 ; Vol. 78. pp. 37-44.
@article{c5cc650aa3c64734a56a5a12cd4e3794,
title = "The impact of stereotactic laser ablation at a typical epilepsy center",
abstract = "Purpose Stereotactic laser ablation (SLA) is a novel form of epilepsy surgery for patients with drug-resistant focal epilepsy. We evaluated one hundred consecutive surgeries performed for patients with epilepsy to address the impact of SLA on our therapeutic approach, as well as patient outcomes. Methods A retrospective, single center analysis of the last one hundred neurosurgeries for epilepsy was performed from 2013 to 2015. Demographics, surgical procedures, and postoperative measures were assessed up to 5 years to compare the effect of SLA on outcome. Confidence intervals (CI) and comparative tests of proportions compared outcomes for SLA and resective surgery. Procedural categorical comparison used Chi-square and Kaplan–Meier curves. Student t-test was utilized for single variables such as age at procedure and seizure onset. Results One hundred surgeries for epilepsy yielded thirty-three SLAs and twenty-one resections with a mean of 21.7-month and 21.3-month follow-up, respectively. The temporal lobe was the most common target for SLA (92.6{\%}) and resection (75{\%}). A discrete lesion was present on brain magnetic resonance imaging (MRI) in 27/32 (84.4{\%}) of SLA patients compared with 7/20 (35{\%}) of resection patients with a normal MRI. Overall, 55–60{\%} of patients became seizure-free (SF). Four of five patients with initial failure to SLA became SF with subsequent resection surgery. Complications were more frequent with resection although SF outcomes did not differ (Chi square; p = 0.79). Stereotactic laser ablation patients were older than those with resections (47.0 years vs. 35.4 years, p = 0.001). The mean length of hospitalization prior to discharge was shorter for SLA (1.18 days) compared with open resection (3.43 days; SD: 3.16 days) (p = 0.0002). Conclusion We now use SLA as a first line therapy at our center in patients with lesional temporal lobe epilepsy (TLE) before resection. Seizure-free outcome with SLA and resection was similar but with a shorter length of stay. Long-term follow-up is recommended to determine sustained SF status from SLA.",
keywords = "Ablation, Epilepsy, Laser, Resection, Seizures, Surgery",
author = "Petito, {Gabrielle T.} and Wharen, {Robert E.} and Anteneh Feyissa and Grewal, {Sanjeet S.} and Lucas, {John A} and Tatum, {William O.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.yebeh.2017.10.041",
language = "English (US)",
volume = "78",
pages = "37--44",
journal = "Epilepsy and Behavior",
issn = "1525-5050",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - The impact of stereotactic laser ablation at a typical epilepsy center

AU - Petito, Gabrielle T.

AU - Wharen, Robert E.

AU - Feyissa, Anteneh

AU - Grewal, Sanjeet S.

AU - Lucas, John A

AU - Tatum, William O.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Purpose Stereotactic laser ablation (SLA) is a novel form of epilepsy surgery for patients with drug-resistant focal epilepsy. We evaluated one hundred consecutive surgeries performed for patients with epilepsy to address the impact of SLA on our therapeutic approach, as well as patient outcomes. Methods A retrospective, single center analysis of the last one hundred neurosurgeries for epilepsy was performed from 2013 to 2015. Demographics, surgical procedures, and postoperative measures were assessed up to 5 years to compare the effect of SLA on outcome. Confidence intervals (CI) and comparative tests of proportions compared outcomes for SLA and resective surgery. Procedural categorical comparison used Chi-square and Kaplan–Meier curves. Student t-test was utilized for single variables such as age at procedure and seizure onset. Results One hundred surgeries for epilepsy yielded thirty-three SLAs and twenty-one resections with a mean of 21.7-month and 21.3-month follow-up, respectively. The temporal lobe was the most common target for SLA (92.6%) and resection (75%). A discrete lesion was present on brain magnetic resonance imaging (MRI) in 27/32 (84.4%) of SLA patients compared with 7/20 (35%) of resection patients with a normal MRI. Overall, 55–60% of patients became seizure-free (SF). Four of five patients with initial failure to SLA became SF with subsequent resection surgery. Complications were more frequent with resection although SF outcomes did not differ (Chi square; p = 0.79). Stereotactic laser ablation patients were older than those with resections (47.0 years vs. 35.4 years, p = 0.001). The mean length of hospitalization prior to discharge was shorter for SLA (1.18 days) compared with open resection (3.43 days; SD: 3.16 days) (p = 0.0002). Conclusion We now use SLA as a first line therapy at our center in patients with lesional temporal lobe epilepsy (TLE) before resection. Seizure-free outcome with SLA and resection was similar but with a shorter length of stay. Long-term follow-up is recommended to determine sustained SF status from SLA.

AB - Purpose Stereotactic laser ablation (SLA) is a novel form of epilepsy surgery for patients with drug-resistant focal epilepsy. We evaluated one hundred consecutive surgeries performed for patients with epilepsy to address the impact of SLA on our therapeutic approach, as well as patient outcomes. Methods A retrospective, single center analysis of the last one hundred neurosurgeries for epilepsy was performed from 2013 to 2015. Demographics, surgical procedures, and postoperative measures were assessed up to 5 years to compare the effect of SLA on outcome. Confidence intervals (CI) and comparative tests of proportions compared outcomes for SLA and resective surgery. Procedural categorical comparison used Chi-square and Kaplan–Meier curves. Student t-test was utilized for single variables such as age at procedure and seizure onset. Results One hundred surgeries for epilepsy yielded thirty-three SLAs and twenty-one resections with a mean of 21.7-month and 21.3-month follow-up, respectively. The temporal lobe was the most common target for SLA (92.6%) and resection (75%). A discrete lesion was present on brain magnetic resonance imaging (MRI) in 27/32 (84.4%) of SLA patients compared with 7/20 (35%) of resection patients with a normal MRI. Overall, 55–60% of patients became seizure-free (SF). Four of five patients with initial failure to SLA became SF with subsequent resection surgery. Complications were more frequent with resection although SF outcomes did not differ (Chi square; p = 0.79). Stereotactic laser ablation patients were older than those with resections (47.0 years vs. 35.4 years, p = 0.001). The mean length of hospitalization prior to discharge was shorter for SLA (1.18 days) compared with open resection (3.43 days; SD: 3.16 days) (p = 0.0002). Conclusion We now use SLA as a first line therapy at our center in patients with lesional temporal lobe epilepsy (TLE) before resection. Seizure-free outcome with SLA and resection was similar but with a shorter length of stay. Long-term follow-up is recommended to determine sustained SF status from SLA.

KW - Ablation

KW - Epilepsy

KW - Laser

KW - Resection

KW - Seizures

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=85034739794&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034739794&partnerID=8YFLogxK

U2 - 10.1016/j.yebeh.2017.10.041

DO - 10.1016/j.yebeh.2017.10.041

M3 - Article

C2 - 29172137

AN - SCOPUS:85034739794

VL - 78

SP - 37

EP - 44

JO - Epilepsy and Behavior

JF - Epilepsy and Behavior

SN - 1525-5050

ER -